Topical therapies in cutaneous lupus - find the right level Victoria Werth #ACR25 SLE guideline session @RheumNow https://t.co/o3gBuFkr4n

#Medical #learners more optimistic re #AI than gen pop’n! Tips stress privacy - pt info in AI goes to private company All trainees will use #AI Set boundaries - change eval where can’t use AI only AI listening notes 👇 #cognitive #deskilling #ACR25 @RheumNow @ACRheum 26S17 https://t.co/UzajaimOcG

For #SLE pleuropericarditis: recommendation intentionally tries to leverage use of colchicine/NSAIDs vs. GCs But there are special situations where GCs are req’d: > Concomitant active SLE > CI to NSAIDs/Col > Recurrent pericarditis > Late pregnancy > 💊interxns #ACR25 @RheumNow https://t.co/sLL72t3Qhf

HIGH YIELD🚨Summary of Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @RheumNow #ACR2025 https://t.co/ysSTKOz1ym

Year in Review: Regency Trial showed that LN pts given obinutuzumab achieved CRR at 76 wks (46.4%) vs. PBO. Take note: the Regency trial did not evaluate the extrarenal effects of Obinutuzumab in #SLE, thats for a diff study. #ACR25 @RheumNow https://t.co/WJssU1DbzZ

#ACR25 New ACR Non-Renal #SLE lifecourse Guideline. 3 strong recommendations: - HCQ routinely unless contraindicated - Taper GC to =< 5mg/d - Escalate therapy in any organ system if refractory to initial therapy *Organ-specific: Conditional recommendations only @RheumNow https://t.co/w9rfcvwGHy

Don’t fight #AI #RCTs - #AI better at soft Skills alone Vs #Medical input and AI as we tend to Disbelieve the model & mess it up! #LLM can accurately take a #history Bottom line EMBRACE AI ?check it too #ACR25 @RheumNow @ACRheum #artificial #intelligence and #medicine 26217 https://t.co/22MYD4QqzH

@ACRheum SLE Treatment Guidelines 2025 Key points: - HCQ is standard - steroids with precision - immunosuppressive therapies early - shared decision making #ACR25 @RheumNow https://t.co/AYIXE6dLlW

Saphnelo (anifrolumab) has been recommended for approval in EU by CHMP for systemic lupus erythematosus (on top of standard therapy) as a once-weekly pre-filled pen. Recommendation based on TULIP-SC Phase III trial. https://t.co/UurvtLNP7S https://t.co/xeKVdVYu3z

Wondering whether rheumatology is the specialty for you? Dr Bryant England kicks off the clinical science #YearInReview with an impressive overview of what a year in rheumatology looks like. New drugs, new devices, new disease names! 🤯 #ChooseRheumatology #ACR25 @RheumNow https://t.co/uLrNFPgeAn

#Sjogren disease is here to stay. “The name has caught up to the science of SD and this can translate to better treatment outcomes for patients” - Dr. Bryant England #ACR25 @RheumNow https://t.co/M4r0XXkswv